AGMB compared with RSVR: revenue, margins and what each company keeps, and the suppliers and customers both name

AGMBAgomab Therapeutics NV

Mkt capRevenueRevenue

RSVRReservoir Media, Inc.

Mkt capRevenueRevenue

Compare

AGMBAgomab Therapeutics NV

RSVRReservoir Media, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

AGMB, solidRSVR, dashed

Supply-chain overlap

Revenue flow

AGMB: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AGMB 0

None

Shared 0

No disclosed counterparties: AGMB.

Only RSVR 9

—FS Mediaunlistedsupplier

—Henry Jackmanunlistedsupplier

—Philly Groove Recordsunlistedsupplier

—PopArabiaunlistedsupplier

5 more · RSVR chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

AGMBAgomab Therapeutics NV

7.14▼−10.14%· post 7.15

Mkt cap$255.9MRevenue—Revenue—

RSVRReservoir Media, Inc.

9.55▼−0.41%· post 9.54

ClosedOct 30 '26

Mkt cap$627.7MRevenue$46MQ3 FY26Revenue$159MFY25

Compare

ClosedOct 30 '26

AGMBAgomab Therapeutics NV

RSVRReservoir Media, Inc.

7.14▼−10.14%post 7.15

Price

9.55▼−0.41%post 9.54

$255.9M

Mkt cap

$627.7M

—

Revenue

$46MQ3 FY26

—

Revenue

$159MFY25

AGMB7.14▼−10.14%vsRSVR9.55▼−0.41%ClosedOct 30 '26